Aurora, CO, United States of America

Clayton Smith

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Colorado. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Clayton Smith. Retrieved from https://idiyas.com/inventor/clayton-smith-deuiq87f

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Clayton Smith - Innovator in Cancer Research

Introduction

Clayton Smith is a notable inventor based in Aurora, CO (US). He has made significant contributions to the field of cancer research through his innovative work. His dedication to reducing cancer stem cells has led to the development of a unique patent that holds promise for cancer treatment.

Latest Patents

Clayton Smith holds a patent titled "Compositions and methods for reducing cancer stem cells." This patent provides compositions and methods aimed at reducing cancer stem cells and/or treating cancer. The innovative aspect of his work includes the use of at least one metabolism modulating agent, and in some cases, at least two metabolism modulating agents.

Career Highlights

Clayton Smith is affiliated with the University of Colorado, where he continues to advance his research in cancer treatment. His work is characterized by a commitment to finding effective solutions for one of the most challenging health issues of our time.

Collaborations

Clayton collaborates with esteemed colleagues such as Craig T. Jordan and Courtney L. Jones. Their combined expertise enhances the research efforts and contributes to the development of effective cancer therapies.

Conclusion

Clayton Smith's innovative work in cancer research exemplifies the impact of dedicated inventors in the medical field. His patent for reducing cancer stem cells represents a significant step forward in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…